[Influence of reintervention by the bacillus of Calmette and Guérin (BCG) on the nonspecific resistance of the mouse to Schistosoma mansoni (author's transl)]. 1979

J Tribouley, and J Tribouley-Duret, and M Apriou

Significant resistance to Schistosoma mansoni appears in mice two weeks after treatment with BCG. The state of nonspecific resistance is considerably increased if the injection of BCG two weeks prior to the infestation test is carried out using mice who have already received BCG. Thus, BCG innoculation in an organism presentized to the bacillus antigens increases immunostimulation. According to these results, during primoinnoculation with BCG, immunostimulation is not significant before this second week, that is, the time necessary for a state of hypersensitivity to appear. Nevertheless, it should be noted that weak yet detectable immunostimulation can be observed before the 14th day following a BCG primoinfection. Thus, the possible role of other mechanisms should be considered.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's
D012550 Schistosoma mansoni A species of trematode blood flukes of the family Schistosomatidae. It is common in the Nile delta. The intermediate host is the planorbid snail. This parasite causes schistosomiasis mansoni and intestinal bilharziasis. Schistosoma mansonus,mansonus, Schistosoma
D012552 Schistosomiasis Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States. Bilharziasis,Katayama Fever,Schistoma Infection,Bilharziases,Fever, Katayama,Infection, Schistoma,Infections, Schistoma,Schistoma Infections,Schistosomiases
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

J Tribouley, and J Tribouley-Duret, and M Apriou
January 1977, Annales d'immunologie,
J Tribouley, and J Tribouley-Duret, and M Apriou
January 1979, Pharmacology & therapeutics,
J Tribouley, and J Tribouley-Duret, and M Apriou
January 2002, Duodecim; laaketieteellinen aikakauskirja,
J Tribouley, and J Tribouley-Duret, and M Apriou
November 1981, Immunology,
J Tribouley, and J Tribouley-Duret, and M Apriou
June 1951, The Journal of experimental medicine,
J Tribouley, and J Tribouley-Duret, and M Apriou
March 1975, Experientia,
J Tribouley, and J Tribouley-Duret, and M Apriou
January 1976, Annales d'immunologie,
J Tribouley, and J Tribouley-Duret, and M Apriou
May 1978, The Journal of infectious diseases,
J Tribouley, and J Tribouley-Duret, and M Apriou
August 1972, Experientia,
J Tribouley, and J Tribouley-Duret, and M Apriou
January 1951, Biologie medicale,
Copied contents to your clipboard!